News

A new gene therapy technology enables the non-invasive control of specific brain circuits, holding promise for studying the brain and finding treatments for neurological conditions.

Scientists developed a nanobody, NbE, that binds tightly to opioid receptors, blocking their activity. This could mitigate the severe side effects of opioids and lead to the creation of smaller, more effective molecules.

Researchers identified more than 200 new vaccine target candidates from SARS-CoV-2, focusing on seven viral proteins beyond the Spike protein. These candidates could enhance immunity by triggering T cell responses.

NUS Medicine researchers are exploring a gene therapy approach for epilepsy linked to the KCNA2 mutation. The therapy uses Gapmer antisense oligonucleotides to target faulty RNA, restoring potassium flow and reducing excessive neuron activity.

Researchers report that 94% of patients treated with the gene therapy eli-cel for cerebral adrenoleukodystrophy (CALD) have maintained neurological function six years post-treatment.

A new graphene oxide platform that mimics the interactions between immune cells could stimulate CAR T cells to reproduce, making CAR T-cell therapy more effective.

Identifying disparities in testing and treating hepatitis C among reproductive-aged women with opioid use disorder can improve health outcomes for all birthing parents and children.

Natural killer T cells could be used to produce antitumor activity in solid tumors.

Researchers have illustrated that synthetic cannabis can reduce agitation in Alzheimer's patients by an average of 30%.

Psychiatric drugs are reported to be about 50% more effective in clinical trials funded by the drug’s manufacturer than when trials of the same drug are sponsored by other groups, new research shows.